As Novo Nordisk’s weight-loss pill Wegovy (semaglutide) readies for a launch in the United States early January, it will be a ...

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

The drugs' high prices, along with spotty insurance coverage, have left them out of reach for many Americans. Read more at ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

In a significant development for global health, U.S. regulators have approved an oral version of the Wegovy weight-loss drug, marking the first time this powerful treatment will be available in pill ...

Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say.

Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

Doctors in the UAE have welcomed the news that anti-obesity drug Wegovy is set to become available as a pill as well as an injection, but have cautioned that it should only be taken under expert ...

Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...

While patients currently must get weekly injections of the weight loss drug Wegovy, the FDA has now approved a daily pill version of the product.